Innovation Pharmaceuticals Inc (IPIX)

[Lemoncat]

You're too low on B imo but you're entitled to yours.

You're also completely writing off Kevetrin. There are many preclinical cancer drugs netting $100 million upfront. Kevetrin appears to be safe and has shown p53 modulation in humans. I think IPIX could do a deal on K but with minimal money from a B deal may be able to substantially increase value with an oral formulation.